Basit öğe kaydını göster

Fosfomycin in the treatment of extended spectrum beta-lactamaseproducing Enterobacteriaceae- related urinary tract infections

dc.contributor.authorTEKCE, Ayse Yasemin Tezer
dc.contributor.authorTonyali, Senol
dc.contributor.authorISIKAY, Levent
dc.contributor.authorCIME, Hakan
dc.contributor.authorTUMTURK, Ayhanim
dc.date.accessioned2021-03-04T10:37:54Z
dc.date.available2021-03-04T10:37:54Z
dc.date.issued2019
dc.identifier.citationTUMTURK A., Tonyali S., TEKCE A. Y. T. , ISIKAY L., CIME H., "Fosfomycin in the treatment of extended spectrum beta-lactamaseproducing Enterobacteriaceae- related urinary tract infections", JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.13, sa.1, ss.73-76, 2019
dc.identifier.issn1972-2680
dc.identifier.othervv_1032021
dc.identifier.otherav_6e321e60-1607-423c-8347-5a9ed26de446
dc.identifier.urihttp://hdl.handle.net/20.500.12627/76083
dc.identifier.urihttps://doi.org/10.3855/jidc.10658
dc.description.abstractIntroduction: We aimed to demonstrate if fosfomycin tromethamine (FT) treatment could be the treatment of choice in ESBL-producing Enterobacteriaceae strains as an alternative to carbapenem particularly in patients who we would like to treat on an outpatient basis.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTemel Bilimler
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri
dc.titleFosfomycin in the treatment of extended spectrum beta-lactamaseproducing Enterobacteriaceae- related urinary tract infections
dc.typeMakale
dc.relation.journalJOURNAL OF INFECTION IN DEVELOPING COUNTRIES
dc.contributor.departmentTurkey Specialized Higher Education & Research Hospital , ,
dc.identifier.volume13
dc.identifier.issue1
dc.identifier.startpage73
dc.identifier.endpage76
dc.contributor.firstauthorID105550


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster